Cancer Survivors- how can we help you?
Cancer survivors and Menopause- A multidisciplinary team (MDT) approach is often used to manage hormone replacement therapy (HRT) in cancer survivors, as the decision to use HRT after cancer treatment is complex and involves multiple factors. Our multidisciplinary team include an oncologist, a menopause specialist and possibly the GP.The team will work together to evaluate your individual risk factors for cancer recurrence, the severity of menopausal symptoms, and the potential benefits and risks of HRT. We will also consider alternative strategies for managing menopausal symptoms, such as lifestyle changes, non-hormonal medications, and alternative therapies.
The oncologist will provide information on the patient's cancer treatment history and the potential impact of HRT on cancer recurrence. The menopause specialist will provide information on the use of HRT for managing menopausal symptoms, including the potential benefits and risks of different types of HRT. The GP will provide ongoing monitoring of the patient's health status.
The aim of a multidisciplinary approach is to provide education and support to you, helping you to make an informed decision about whether or not to use HRT. Together we will discuss the potential benefits and risks of HRT, including the potential impact on cancer recurrence, and will help you to weigh up these factors in light of your individual medical history and overall health status.
Ultimately, the goal of our multidisciplinary team approach is to provide individualised, patient-centred care that addresses the unique needs and concerns of each cancer survivor. We will work together as a team to ensure that you receive the best possible care, whether or not HRT is recommended.